| 1 |
34755269 | Colchicine Is Safe Though Ineffective in the Treatment of Severe COVID-19: a Randomized Clinical Trial (COLCHIVID). | 2022 Jan |
1 |
| 2 |
32598947 | The development of a targeted and more potent, anti-Inflammatory derivative of colchicine: Implications for gout. | 2020 Oct |
1 |
| 3 |
31877739 | Design and Biological Evaluation of Colchicine-CD44-Targeted Peptide Conjugate in an In Vitro Model of Crystal Induced Inflammation. | 2019 Dec 21 |
1 |
| 4 |
28189686 | Interleukin-8 enhances the effect of colchicine on cell death. | 2017 Mar 25 |
5 |
| 5 |
19434815 | Treatment with levamisole and colchicine can result in a significant reduction of IL-6, IL-8 or TNF-alpha level in patients with mucocutaneous type of Behcet's disease. | 2009 May |
2 |
| 6 |
9025904 | Immunofluorescence assay for the quantitative and qualitative evaluation of intracellular interleukin-8 in microtiter plates. | 1997 Jan 1 |
1 |
| 7 |
8543832 | Cellular detachment and deformation induce IL-8 gene expression in human bronchial epithelial cells. | 1996 Jan 15 |
1 |
| 8 |
22827272 | Production of IL-8 and the other cytokines by T cell clones established from the ocular fluid of patients with Behçet's disease. | 1995 |
1 |
| 9 |
8371232 | Interleukin 8: the major neutrophil chemotaxin in a case of pseudogout. | 1993 Jul |
3 |
| 10 |
2155963 | Functional activation of human neutrophils by recombinant monocyte-derived neutrophil chemotactic factor/IL-8. | 1990 Mar 15 |
2 |